Skip to content
Sign in

TWST · NASDAQ

Twist Bioscience (TWST) Stock Price & Fundamentals

$529.38−0.89%−$4.74End-of-day price as of Oct 9, 2026

Twist Bioscience (TWST) closed at $529.38 on Oct 9, 2026, down 0.89% from the previous close of $534.12.

Share price, past year

1Y +2.70%

52-week range $459.27 – $549.82. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$529.38
Sep 30, 2026$524.38
Aug 31, 2026$536.53
Jul 31, 2026$531.78
Jun 30, 2026$494.22
May 29, 2026$494.30
Apr 30, 2026$494.56
Mar 31, 2026$497.52
Feb 27, 2026$503.39
Jan 30, 2026$504.32
Dec 31, 2025$510.69
Nov 28, 2025$522.73
Oct 31, 2025$536.97

Key statistics

Market cap
$33.18B
P/E (TTM)
—
EPS (TTM)
−$2.21
Revenue (TTM)
$431.80M
Net income (TTM)
−$136.72M
Shares outstanding
62.7M
Dividend yield
—
52-week range
$459.27 – $549.82

Twist Bioscience's market cap is $33.18B, based on a share price of $529.38 and 62.7M shares outstanding as of Jun 30, 2026.

Financials

Twist Bioscience reported revenue of $376.57M for fiscal 2025, up 20.32% from fiscal 2024.

Twist Bioscience reported a net loss of $77.67M in fiscal 2025.

Fiscal 2025 revenue was the highest in the 9 years shown.

Annual revenue

FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Twist Bioscience annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Sep 30, 2025$376.57M+20.3%−$77.67M−20.6%−$1.30−$75.63M
FY2024ended Sep 30, 2024$312.97M+27.7%−$208.73M−66.7%−$3.60−$69.17M
FY2023ended Sep 30, 2023$245.11M+20.4%−$204.62M−83.5%−$3.60−$170.25M
FY2022ended Sep 30, 2022$203.57M+53.8%−$217.86M−107.0%−$4.04−$226.24M
FY2021ended Sep 30, 2021$132.33M+46.9%−$152.10M−114.9%−$3.15−$139.31M
FY2020ended Sep 30, 2020$90.10M+65.7%−$139.93M−155.3%−$3.57−$152.12M
FY2019ended Sep 30, 2019$54.39M+113.9%−$107.67M−198.0%−$3.92−$102.69M
FY2018ended Sep 30, 2018$25.43M+136.2%−$71.24M−280.2%−$25.51−$69.85M
FY2017ended Sep 30, 2017$10.77M—−$59.31M−550.9%−$24.49−$57.90M
Twist Bioscience quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q3 FY2026ended Jun 30, 2026$118.38M−$35.05M−$0.56
Q2 FY2026ended Mar 31, 2026$110.72M−$44.02M−$0.71
Q1 FY2026ended Dec 31, 2025$103.70M−$30.51M−$0.50
Q4 FY2025ended Sep 30, 2025$99.01M−$27.14M−$0.44
Q3 FY2025ended Jun 30, 2025$96.06M$20.39M$0.33
Q2 FY2025ended Mar 31, 2025$92.79M−$39.33M−$0.66
Q1 FY2025ended Dec 31, 2024$88.71M−$31.59M−$0.53
Q4 FY2024ended Sep 30, 2024$84.71M−$34.66M−$0.59

Company profile

Name
Twist Bioscience Corp
Ticker
TWST
Exchange
NASDAQ
Industry (SEC SIC)
Biological Products, (No Diagnostic Substances)
Headquarters
681 Gateway Blvd., South San Francisco, CA 94080
Incorporated in
DE
Fiscal year ends
September
SEC CIK
0001581280

Recent SEC filings

Frequently asked questions

What is Twist Bioscience's stock price?

Twist Bioscience (TWST) closed at $529.38 on Oct 9, 2026, down 0.89% from the previous close of $534.12.

What is Twist Bioscience's market cap?

Twist Bioscience's market cap is $33.18B, based on a share price of $529.38 and 62.7M shares outstanding as of Jun 30, 2026.

How much revenue does Twist Bioscience make?

Twist Bioscience reported revenue of $376.57M for fiscal 2025, up 20.32% from fiscal 2024.

Does Twist Bioscience pay a dividend?

Twist Bioscience's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Twist Bioscience Corp's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures